New Delhi: The Central government on Saturday cautioned about an emerging threat called mucormycosis even as the country is still dealing with the havoc created by the second wave of the Covid19 pandemic.
The Union Ministry of Health and Family Welfare (MoHFW) has asked all the States and Union Territories (UTs) to keep a tab on the issue of mucormycosis.
“This is an emerging issue. We have asked all the states and UTs to be on alert,” said Dr VK Paul, chairperson of the national task force on Covid19 and a Niti Aayog member.
He said that though the number of mucormycosis infections is very minimal at present, the central government is looking into the production of amphotericin B, an antifungal medication used for serious fungal infections and leishmaniasis.
Mucormycosis or black fungus is a complication caused by fungal infection. People catch mucormycosis by coming in contact with the fungal spores in the environment. It can also develop on the skin after the fungus enters the skin through a cut, scrape, burn, or other types of skin trauma.
The disease is being detected among patients who are recovering or have recovered from Covid-19. Anyone who is diabetic and whose immune system is not functioning well needs to be on the guard against this.
Read: Rising Cases Of The Black Fungal Infection In India!
“Mucormycosis is a serious problem. It mainly occurs in patients having diabetes, Covid and those who are on steroids. So, there is an urgent need to control diabetes and avoid taking unnecessary steroids,” said Dr Paul while addressing a press conference in New Delhi on the status of Covid19 situation.